Akoya Biosciences Stock In The News

AKYA Stock  USD 2.14  0.06  2.73%   
Our overall analysis of Akoya Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Akoya Biosciences. The specific impact of Akoya Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Akoya Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Akoya Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Akoya Biosciences Backtesting and Akoya Biosciences Hype Analysis.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.

Akoya Biosciences Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
https://www.globenewswire.com/news-release/2023/11/08/2776648/0/en/Akoya-Reports-Record-Revenue-in-the-Third-Quarter-of-2023-and-Reiterates-Full-Year-2023-Revenue-Guidance.html
 Neutral
Macroaxis News: globenewswire.com
Akoya to Participate at Three Upcoming Investor Conferences
https://www.globenewswire.com/news-release/2023/11/02/2772246/0/en/Akoya-to-Participate-at-Three-Upcoming-Investor-Conferences.html
 Neutral
Macroaxis News: globenewswire.com
Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023
https://www.globenewswire.com/news-release/2023/10/31/2770244/0/en/Akoya-Biosciences-to-Showcase-New-Spatial-Biology-2-0-Solutions-and-Spatial-Phenotyping-Data-at-SITC-2023.html
 Neutral
Macroaxis News: globenewswire.com
Akoya Biosciences Announces Peer-Reviewe...
https://www.globenewswire.com/news-release/2023/10/17/2761697/0/en/Akoya-Biosciences-Announces-Peer-Reviewed-Publication-Using-Ultrahigh-Plex-Spatial-Phenotyping-of-Head-and-Neck-Cancer-to-Identify-Distinct-Immune-and-Metabolic-Signatures.html
 Neutral
Macroaxis News: globenewswire.com
Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023
https://www.globenewswire.com/news-release/2023/10/11/2758806/0/en/Akoya-to-Report-Third-Quarter-2023-Financial-Results-on-November-8th-2023.html
 Bullish
Macroaxis News: globenewswire.com
Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms
https://www.globenewswire.com/news-release/2023/09/19/2745518/0/en/Akoya-Biosciences-Sets-a-New-Standard-for-Scaling-Spatial-Biology-with-the-Launch-of-2-0-Platforms.html
 Bullish
Yahoo News
10 Healthcare Stocks with Insider Buying
https://finance.yahoo.com/news/10-healthcare-stocks-insider-buying-135635311.html
 Bullish
Macroaxis News: globenewswire.com
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
https://www.globenewswire.com/news-release/2023/08/07/2720136/0/en/Akoya-Reports-Record-Revenue-in-the-Second-Quarter-of-2023-and-Reiterates-Full-Year-2023-Revenue-Guidance.html
 Neutral
Macroaxis News: globenewswire.com
Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies
https://www.globenewswire.com/news-release/2023/08/07/2719672/0/en/Akoya-Biosciences-Announces-Milestone-of-1-000-Peer-Reviewed-Publications-Citing-Use-of-its-Spatial-Biology-Technologies.html
 Bullish
Macroaxis News: globenewswire.com
Akoya to Participate at Three Upcoming Investor Conferences
https://www.globenewswire.com/news-release/2023/07/26/2711661/0/en/Akoya-to-Participate-at-Three-Upcoming-Investor-Conferences.html
 Neutral

Akoya Biosciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Akoya and other traded companies coverage with news coverage. We help investors stay connected with Akoya headlines for the 29th of November to make an informed investment decision based on correlating the impacts of news items on Akoya Stock performance. Please note that trading solely based on the Akoya Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Akoya Biosciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Akoya Biosciences investors visualize upcoming and past events in order to time the market based on Akoya Biosciences noise-free hype analysis.
Akoya Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Akoya earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Akoya Biosciences that are available to investors today. That information is available publicly through Akoya media outlets and privately through word of mouth or via Akoya internal channels. However, regardless of the origin, that massive amount of Akoya data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Akoya Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Akoya Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Akoya Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Akoya Biosciences alpha.

Akoya Largest EPS Surprises

Earnings surprises can significantly impact Akoya Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-14
2024-09-30-0.2-0.17860.021410 
2021-08-10
2021-06-30-0.23-0.20.0313 
2024-03-04
2023-12-31-0.27-0.220.0518 
2022-05-05
2022-03-31-0.39-0.44-0.0512 
2021-11-08
2021-09-30-0.26-0.31-0.0519 
2023-03-06
2022-12-31-0.43-0.5-0.0716 
View All Earnings Estimates

Akoya Biosciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Akoya Biosciences Stock. Current markets are slightly bullish. About 51% of major world exchanges and indexes are currently up. See today's market update for more information.
Investing News at Macroaxis
19th of November 2024
Akoya Biosciences stock target cut, rating held on recent earnings report
at investing.com 
insidermonkey News
15th of November 2024
Akoya Biosciences, Inc. Q3 2024 Earnings Call Transcript
at insidermonkey.com 
Gurufocus Stories at Macroaxis
14th of November 2024
Akoya Biosciences Inc Q3 2024 Earnings Revenue Misses Estimates at 18. ...
at gurufocus.com 
Gurufocus Stories at Macroaxis
13th of November 2024
Akoya Biosciences Inc Q3 2024 Earnings Report Preview What To Look For
at gurufocus.com 
Macroaxis News: globenewswire.com
28th of October 2024
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
at globenewswire.com 
Macroaxis News
2nd of October 2024
Acquisition by Mendel Scott of 44959 shares of Akoya Biosciences at 2.68 subject to Rule 1...
at MacroaxisInsider 
Simply Wall St News at Macroaxis
13th of September 2024
Akoya Biosciences, Inc.s biggest owners are private equity firms who got richer after stoc...
at simplywall.st 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Akoya Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Akoya Biosciences' short interest history, or implied volatility extrapolated from Akoya Biosciences options trading.
When determining whether Akoya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akoya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akoya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akoya Biosciences Stock:
Check out Akoya Biosciences Backtesting and Akoya Biosciences Hype Analysis.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akoya Biosciences. If investors know Akoya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akoya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.16)
Revenue Per Share
1.889
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.18)
Return On Equity
(1.28)
The market value of Akoya Biosciences is measured differently than its book value, which is the value of Akoya that is recorded on the company's balance sheet. Investors also form their own opinion of Akoya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Akoya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akoya Biosciences' market value can be influenced by many factors that don't directly affect Akoya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akoya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akoya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akoya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.